Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by nobody – 2019-04-03 13:36 (746 d 11:10 ago) – Posting: # 20119
Views: 2,605

» This is not always entirely straightforward.

I like this kind of understatement. In fact you are in full-blow development mode for sumfink like that.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time: Monday 00:47 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5